BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 36313744)

  • 1. Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy.
    Du S; Shi H; Xiong L; Wang P; Shi Y
    Front Endocrinol (Lausanne); 2022; 13():1011669. PubMed ID: 36313744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canagliflozin Attenuates Lipotoxicity in Cardiomyocytes by Inhibiting Inflammation and Ferroptosis through Activating AMPK Pathway.
    Zhang W; Lu J; Wang Y; Sun P; Gao T; Xu N; Zhang Y; Xie W
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexmedetomidine ameliorates diabetic cardiomyopathy by inhibiting ferroptosis through the Nrf2/GPX4 pathway.
    Li F; Hu Z; Huang Y; Zhan H
    J Cardiothorac Surg; 2023 Jul; 18(1):223. PubMed ID: 37430319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-Gingerol Alleviates Ferroptosis and Inflammation of Diabetic Cardiomyopathy via the Nrf2/HO-1 Pathway.
    Wu S; Zhu J; Wu G; Hu Z; Ying P; Bao Z; Ding Z; Tan X
    Oxid Med Cell Longev; 2022; 2022():3027514. PubMed ID: 36624878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the impact of ferroptosis on diabetic cardiomyopathy: a systematic review.
    Lou X; Zhang Y; Guo J; Gao L; Ding Y; Zhuo X; Lei Q; Bian J; Lei R; Gong W; Zhang X; Jiao Q
    Heart Fail Rev; 2024 Jan; 29(1):1-11. PubMed ID: 37555989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canagliflozin attenuates thioacetamide-induced liver injury through modulation of HMGB1/RAGE/TLR4 signaling pathways.
    Abdelmageed ME; Abdelrahman RS
    Life Sci; 2023 Jun; 322():121654. PubMed ID: 37023955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosis.
    Sun X; Chen RC; Yang ZH; Sun GB; Wang M; Ma XJ; Yang LJ; Sun XB
    Food Chem Toxicol; 2014 Jan; 63():221-32. PubMed ID: 24269735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canagliflozin mitigates ferroptosis and ameliorates heart failure in rats with preserved ejection fraction.
    Ma S; He LL; Zhang GR; Zuo QJ; Wang ZL; Zhai JL; Zhang TT; Wang Y; Ma HJ; Guo YF
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Aug; 395(8):945-962. PubMed ID: 35476142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ROS and iron homeostasis dependent ferroptosis play a vital role in 5-Fluorouracil induced cardiotoxicity in vitro and in vivo.
    Li D; Song C; Zhang J; Zhao X
    Toxicology; 2022 Feb; 468():153113. PubMed ID: 35101590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of FXN overexpression on ferroptosis in L-Glu-induced SH-SY5Y cells.
    Wang M; Xuan T; Li H; An J; Hao T; Cheng J
    Acta Histochem; 2024 Jan; 126(1):152135. PubMed ID: 38266318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of canagliflozin on pancreatic cancer are mediated via the downregulation of glucose transporter‑1 and lactate dehydrogenase A.
    Xu D; Zhou Y; Xie X; He L; Ding J; Pang S; Shen B; Zhou C
    Int J Oncol; 2020 Nov; 57(5):1223-1233. PubMed ID: 32901837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway.
    Yang X; Liu Q; Li Y; Tang Q; Wu T; Chen L; Pu S; Zhao Y; Zhang G; Huang C; Zhang J; Zhang Z; Huang Y; Zou M; Shi X; Jiang W; Wang R; He J
    Adipocyte; 2020 Dec; 9(1):484-494. PubMed ID: 32835596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIRT6‑specific inhibitor OSS‑128167 exacerbates diabetic cardiomyopathy by aggravating inflammation and oxidative stress.
    Huang Y; Zhang J; Xu D; Peng Y; Jin Y; Zhang L
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin ameliorates diabetic nephropathy through inhibiting oxidative stress and ferroptosis signaling.
    Zhang Y; Qu Y; Cai R; Gao J; Xu Q; Zhang L; Kang M; Jia H; Chen Q; Liu Y; Ren F; Zhou MS
    Eur J Pharmacol; 2024 Aug; 976():176699. PubMed ID: 38825302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenesis of chronic heart failure in rats based on ferroptosis-mediated oxidative stress and intervention effect of Shenfu Injection].
    Wang ZY; Zhang Q; Guo J; Huang SM; Meng LC; Hu ZX
    Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(19):5285-5293. PubMed ID: 38114118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taohuajing reduces oxidative stress and inflammation in diabetic cardiomyopathy through the sirtuin 1/nucleotide-binding oligomerization domain-like receptor protein 3 pathway.
    Yao R; Cao Y; Wang C; Xu L; Zhang X; Deng Y; Li F; Wang S
    BMC Complement Med Ther; 2021 Feb; 21(1):78. PubMed ID: 33637069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperbaric oxygen protects HT22 cells and PC12 cells from damage caused by oxygen-glucose deprivation/reperfusion via the inhibition of Nrf2/System Xc-/GPX4 axis-mediated ferroptosis.
    Chen C; Chen W; Zhou X; Li Y; Pan X; Chen X
    PLoS One; 2022; 17(11):e0276083. PubMed ID: 36355759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Noncoding RNA OIP5-AS1 Overexpression Promotes Viability and Inhibits High Glucose-Induced Oxidative Stress of Cardiomyocytes by Targeting MicroRNA-34a/SIRT1 Axis in Diabetic Cardiomyopathy.
    Sun H; Wang C; Zhou Y; Cheng X
    Endocr Metab Immune Disord Drug Targets; 2021; 21(11):2017-2027. PubMed ID: 33380310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canagliflozin protects diabetic cardiomyopathy by mitigating fibrosis and preserving the myocardial integrity with improved mitochondrial function.
    Dasari D; Goyal SG; Penmetsa A; Sriram D; Dhar A
    Eur J Pharmacol; 2023 Jun; 949():175720. PubMed ID: 37054940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maresin-1 inhibits high glucose induced ferroptosis in ARPE-19 cells by activating the Nrf2/HO-1/GPX4 pathway.
    Li Y; Liu J; Ma X; Bai X
    BMC Ophthalmol; 2023 Sep; 23(1):368. PubMed ID: 37674121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.